Awards as PI
| Award Value | ||
|---|---|---|
| Early Translational IV | Use of human iPSC-derived neurons from Huntington’s Disease patients to develop novel, disease-modifying small molecule structural corrector drug candidates targeting the unique, neurotoxic conformation of mutant huntingtin | $938,391 |
Total: $938,391.00 |
Search CIRM grants
Follow Us
